Skip to main content

Table 4 Multivariate analysis of Clinicopathological features, tumor markers, and patient survival

From: Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy

Variable PFS HR (95% CI) P value OS HR (95% CI) P value
ERCC1 (positive vs. negative) 0.427 (0.211-0.864) 0.018* 0.447 (0.219-0.911) 0.027*
BAG-1 (positive vs. negative) 0.474 (0.257-0.874) 0.017* 0.486 (0.262-0.901) 0.022*
Metastasis lymphatics (Yes vs. No) 0.627 (0.299-1.315) 0.217 0.654 (0.352-1.370) 0.260
TNM stage (I + II vs. III + IV) 0.699 (0.336-1.457) 0.340 1.442 (0.691-2.984) 0.324
  1. * represent P < 0.05